Human Birth Tissue Composition for Inflammation and Pain Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional methods for treating neurogenic inflammation and pain, such as those caused by viral infections like herpes, often provide only temporary relief and are associated with significant side effects, necessitating a safer and more effective treatment option.
Innovation Solution
Administration of a human birth tissue material composition, including components like placental tissue and amniotic fluid, to affected sites in the body, which can be prepared by screening and processing placental tissue from healthy donors to ensure safety and efficacy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional methods such as NSAIDs, antidepressants, and antiviral medications are used to treat pain and inflammation, then temporary relief is provided, but serious side effects occur from prolonged use
Solution Approach 1:
The patent uses human birth tissue material (placenta, amniotic fluid, umbilical cord) as an intermediary substance to treat pain and inflammation. This biological mediator provides therapeutic effects through natural regenerative properties and anti-inflammatory factors, avoiding the harmful side effects of conventional pharmaceuticals while maintaining treatment effectiveness
Solution Approach 2:
The invention changes the fundamental parameter of treatment from chemical-pharmaceutical to biological-tissue-based therapy. By transitioning from synthetic drugs (NSAIDs, antivirals) to biological materials containing growth factors, cytokines, and regenerative cells, the treatment achieves sustained relief without the cumulative side effects associated with long-term pharmaceutical use
2Ease of operation
If conventional treatments are used to mask symptoms, then temporary relief is achieved, but the underlying condition progresses
Solution Approach 1:
The birth tissue material is prepared and processed in advance to concentrate therapeutic factors including growth factors, cytokines, and regenerative cells. This preliminary preparation ensures that when administered, the material immediately begins addressing both symptoms and underlying pathology, rather than merely masking symptoms as conventional treatments do
Solution Approach 2:
The human birth tissue material contains self-regulating therapeutic components that actively work to restore tissue health and address the underlying condition. The biological materials exhibit self-repair and regenerative properties, enabling the treatment to adapt and respond to the specific needs of the affected tissue rather than providing uniform symptomatic relief
Data Source
AI summary
Methods of treating inflammation, pain or both inflammation and pain in a subject are provided. The method includes the step of administering a human birth tissue material composition on or within an affected site of a body. The methods are particularly suitable for treatment of inflammation, pain or both inflammation and pain arising from a viral infection.